Authors


Laura Newman

Latest:

Triple therapy offers local control for high-risk PCa

New York-A combination of hormonal therapy, brachytherapy, andexternal beam radiation has demonstrated excellent local control in high-riskprostate cancer patients.


Nancy Groves

Latest:

Sexual dysfunction seen with Thulium laser therapy for benign prostatic hyperplasia

Filling a gap in the knowledge of the incidence of sexual dysfunction following Thulium YAG vaporesection (ThuVaRP), a recent study found that the risk of erectile dysfunction was 20%, while that of retrograde ejaculation was 56% in a group of patients who had been sexually active before the procedure.


Laszlo Dosa

Latest:

Highly toxic chemo may be effective in bladder TCC

Atlanta-Neoadjuvant chemotherapy using a three-drug combination has demonstrated activity in locally advanced transitional cell carcinoma (TCC) of the bladder, but it also possesses considerable toxicity. That was the conclusion reported in a poster by University of Michigan researchers at the American Society of Clinical Oncology annual meeting.


Robert H. Carlson

Latest:

New drug targets considered for erectile dysfunction

Paris-Basic research in erectile dysfunction therapy is being hamperedby the attitude of some funding bodies that phosphodiesterase type-5 inhibitorsalone have solved all problems, according to a special committee convenedat the 2nd International Consultation on Erectile and Sexual Dysfunctionshere.


Andrew Bowser

Latest:

Prostate Ca patients urged to consult a medical oncologist

New York--Men with prostate cancer are being urged to seek the advice of a medical oncologist in a new educational campaign launched by the Prostate Cancer Foundation.


Anne Scheck

Latest:

Antibiotics lower PSA in patients with prostatitis

San Francisco--Elevated PSA levels in men who have chronic bacterial prostatitis return to normal after antimicrobial treatment with either levofloxacin (Levaquin) or ciprofloxacin (Cipro), according to researchers from Northwestern University and Ortho-McNeil Pharmaceutical.


Mac Overmyer

Latest:

Does specialty affect sling complication rate?

Gynecologists derive higher complication rates than urologists during the first 30 days following sling procedures for urinary incontinence, according to a multicenter study presented at the European Association of Urology annual congress in Munich, Germany.


Cheryl Guttman Krader, BS, Pharm

Latest:

Bipolar techniques show advantages in treating benign prostatic hyperplasia

Results from a prospective, randomized controlled clinical trial suggest that bipolar plasma vaporization of the prostate is a promising advance in the surgical treatment of BPH in men with average-size prostates.


Charles Bankhead

Latest:

BPH: Current, forthcoming modalities show efficacy

Four-year data on the prostatic urethral lift (UroLift) and data on a new water-jet ablation treatment were among BPH/LUTS highlights from this year’s meeting.


Tim Snider

Latest:

Stone progression preventable in private practice

Chicago-A private practice setting can be just as successful with renal stone prevention as a larger academic setting, according to research presented at the AUA annual meeting here. And, if treatment is needed later, a patient can be counseled about options following an accurate assessment of the natural progression of stones.



Mark E. Battersby

Latest:

How to reduce your biggest tax bill: property taxes

Tax planning has long been an extremely effective tool used by many urologiststo keep their tax bills to a minimum. Often overlooked in this ongoing battlefor legitimately lower tax bills, however, is the biggest tax bill facedby many physicians and their practices: property taxes. Even those utilizingrented property for their practices are impacted by property taxes.


Bob Gatty

Latest:

Election Day holds many keys to urologists' future

The decisions by the men and women who are elected will determine whether physicians who treat Medicare are fairly reimbursed; whether the Independent Payment Advisory Board (IPAB) is allowed to continue; and even how government agencies, task forces, and advisory boards that make recommendations on specific testing and treatment protocols are allowed to function.


Kevin C. Smith

Latest:

How to 'meet' with a remote audience via videoconference

Take advantage of a high-capacity Internet connection when setting upmeetings


Neil H. Baum, MD

Latest:

Dr. Neil Baum's 10 tips for being on time as a physician

"There are opportunities for doctors to become more productive, to see more patients, and to avoid the erosion of their incomes," writes Neil Baum, MD.


Bob Roehr

Latest:

Combo drug treatment works for bladder Ca BCG failures

Bethesda, MD-A combination of low-dose bacille Calmette-Guin and interferon-alpha (IFN-a) has shown promise in the treatment of bladder cancer patients who have failed initial treatment with BCG.


Michael T. McCue

Latest:

Thompson: 'It's time for a national solution'

In this exclusive Urology Times interview, Health and Human Services Secretary Tommy G. Thompson addresses the medical liability insurance crisis and outlines several possible solutions. Thompson also discusses the future of managed care, his plans for restructuring Medicare, and his goals for HHS during his tenure. The interview was conducted by Michael T. McCue, editor-in-chief of Managed Healthcare Executive, a UT sister publication.


John Schieszer

Latest:

General urologists less likely to utilize third-line OAB treatments

General urologists are less likely to utilize third-line interventions for overactive bladder than those with additional female pelvic medicine and reconstructive surgery training.


William F. Gee, MD

Latest:

Urologists are well positioned for 2010

In spite of the chaos of health care reform, urologists' mix of office, outpatient surgery, and hospital practice ensures that we will continue to do well.


John J. Mulcahy, MD, PhD

Latest:

ED after PCa therapy: Still problematic, but treatable

Patients should be advised that ED is a good possibility with any form of treatment.


Ray Painter, MD

Latest:

Urologists should avoid unbundling instillation, in/out catheter

Make sure that you are coding correctly for the instillation based on the type of drug you are using and charge separately for the drugs that are instilled.


Arieh Shalhav, MD

Latest:

Managing laparoscopic injuries: An addendum

This addendum includes advice on managing gas emboli/vascular insufflation,vascular injuries, subcutaneous emphysema, pneumomediastinum, and pneumothoraxArieh L. Shalhav, MD, is associate professor of surgery and directorof minimally invasive urology, and Marcelo A. Orvieto, MD, is a fellowin minimally invasive urology, University of Chicago.As discussed in a recent "Hands On" article ("How to preventand manage laparoscopic injuries," July 2003, page 50), the overallcomplication rate related to urologic laparoscopy is approximately 4%, varyingwidely according to the procedure's technical difficulty. In this addendumto the article, we discuss how urologists can prevent and manage additionalcomplications associated with laparoscopy, including gas emboli/vascularinsufflation, vascular injuries, subcutaneous emphysema, pneumomediastinum,and pneumothorax.


J. Curtis Nickel, MD

Latest:

Managing chronic prostatitis: A modern approach

Nearly one in 10 men who walk into the outpatient office of a urologist leave with a coded diagnosis of prostatitis. Urologists have described the traditional approach to the diagnosis and management of the chronic prostatitis syndromes as one of the most frustrating areas of urologic practice.


Willet F. Whitmore, III, MD

Latest:

How to perform transperineal saturation prostate biopsy

The inherent limitations of the standard transrectal ultrasound approach for prostate biopsy have led to both diagnostic and therapeutic dilemmas.


Winston E. Barzell, MD

Latest:

How to perform transperineal saturation prostate biopsy

The inherent limitations of the standard transrectal ultrasound approach for prostate biopsy have led to both diagnostic and therapeutic dilemmas.


Emma Hitt, PhD

Latest:

Neoadjuvant chemo is well tolerated in high-risk PCa

Atlanta-Neoadjuvant docetaxel added to androgen suppression therapy and radiation therapy appears to be safe and active in patients with high-risk localized prostate cancer, according to findings of a new phase II study from Canada reported here at the American Society of Clinical Oncology annual meeting.


Craig S. Niederberger, MD

Latest:

Infertility story offers a lesson for all urologists

This story about the operating microscope and the vas has two morals.


Schlomo Raz, MD

Latest:

Evidence-based medicine drives new approach to SUI

The lifetime risk of undergoing surgery for incontinence or vaginal prolapsein the United States is nearly one in 11. As our population ages and lifeexpectancies increase, a greater number of women will present with pelvicfloor and voiding disorders. Because of this, there is significant interestin using evidence-based research to assess current diagnostic tools in theevaluation of stress urinary incontinence (SUI), as well as new potentialtreatments.


Nancy B. Itano, MD

Latest:

Evidence-based medicine drives new approach to SUI

The lifetime risk of undergoing surgery for incontinence or vaginal prolapsein the United States is nearly one in 11. As our population ages and lifeexpectancies increase, a greater number of women will present with pelvicfloor and voiding disorders. Because of this, there is significant interestin using evidence-based research to assess current diagnostic tools in theevaluation of stress urinary incontinence (SUI), as well as new potentialtreatments.


Richard D. Williams, MD

Latest:

NFL, other partners help drive American Urological Association Foundation initiative

Sandra Vassos, MPH, executive director of the AUAF, discusses the foundation's increasingly visible initiatives.

© 2025 MJH Life Sciences

All rights reserved.